When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Charcot-Marie-Tooth disease

Última revisão: 25 Mar 2025
Última atualização: 09 May 2024

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • family history of neuropathy, pes cavus, or abnormal gait
  • walking difficulties
  • pes cavus
  • steppage gait
  • diffuse deep tendon hyporeflexia or areflexia
  • reduced muscle strength
  • reduced sensation
  • transient sensory symptoms
  • transient motor symptoms
Detalhes completos

Outros fatores diagnósticos

  • past surgery to feet and ankles
  • balance difficulties in childhood
  • ankle weakness
  • sensory abnormalities in hands and feet
  • toe-walking
  • delayed motor milestones
  • sensory ataxia
  • kyphoscoliosis
Detalhes completos

Fatores de risco

  • family history of neuropathy, pes cavus (high foot arches with hammer toes), or abnormal gait
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • nerve conduction studies (NCS)
Detalhes completos

Investigações a serem consideradas

  • genetic testing
  • hip x-ray
  • x-rays of cervical, thoracic, and lumbar spine and pelvis
  • nerve ultrasound
  • nerve biopsy
  • pulmonary function testing
Detalhes completos

Algoritmo de tratamento

CONTÍNUA

all patients

Colaboradores

Autores

Carly E. Siskind, MS, CGCL

Clinical Assistant Professor (Affiliated)

Certified Genetic Counselor

Stanford Health Care

Stanford University

Stanford

CA

Declarações

CES has an unpaid position on the Charcot-Marie-Tooth Association Advisory board. CES is a consultant for Guidepoint, conducting approximately five consultations a year of which may include consults for Charcot-Marie-Tooth disease. CES has received institutional funding from an Inherited Neuropathies Consortium research grant, funded by the Muscular Dystrophy Association and the National Institute for Health. CES gives lectures to Genetics graduate students at Stanford University. CES has professional relationships with some authors of references cited in this topic.

Agradecimentos

Dr Carly E. Siskind would like to gratefully acknowledge Prof Richard A Lewis, her previous co-contributor to this topic.

Declarações

RAL is a consultant for Pharnext, CSL Behring, and Axelacare. He is on the Medical Advisory Board for GBS-CIDP Foundation, MGFA, and MGF of Ca. He has done expert testimony related to GBS, CIDP, and other neurologic disorders, and educational talks for AAN, AANEM, CSL Behring, and Optioncare. With the exception of Pharnext, none of these relationships are related to Charcot-Marie-Tooth disease. RAL is an author of a number of references cited in this topic.

Revisores

Reza Sadjadi, MD

Neurologist

Director, Charcot-Marie-Tooth (CMT) Center of Excellence

Assistant Professor of Neurology

Harvard Medical School

Boston

MA

Declarações

RS declares that he has no competing interests.

Pavel Seeman, MD, PhD

Associate Professor (Doc)

Head of the DNA Laboratory

Department of Child Neurology

Second School of Medicine

Charles University

Prague

and University Hospital Motol

Prague

Czech Republic

Declarações

PS declares that he has no competing interests.

  • Charcot-Marie-Tooth disease images
  • Diagnósticos diferenciais

    • Diabetic neuropathy
    • Chronic inflammatory demyelinating polyneuropathy
    • Acquired peripheral neuropathy
    Mais Diagnósticos diferenciais
  • Diretrizes

    • Clinical practice guideline for the management of paediatric Charcot-Marie-Tooth disease
    • Differential diagnosis of acquired and hereditary neuropathies in children and adolescents-consensus-based practice guidelines
    Mais Diretrizes
  • Folhetos informativos para os pacientes

    Osteoarthritis

    Diabetes: What can I do to keep healthy?

    Mais Folhetos informativos para os pacientes
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal